Eager attendees of the upcoming COMPAMED trade fair in Düsseldorf this week, Wednesday, November 12 - 14, will have an opportunity to witness a demonstration of a groundbreaking medical device that can assist physicians dealing with prostate cancer in identifying a benign prostate tissue change from a more concerning malignancy.

The company behind this novel diagnostic device is Europe's largest application-oriented research organization, Fraunhofer, who claims it can distinguish between the two types of tissue alterations within a minute-and-a-half via an integrated visual analysis of a biopsy.

Operating the device is simple enough. After obtaining a biopsy of the prostate tissue, clinicians simply place it on a base plate and slide it into the machine before pressing a button to allow the device to study the sample. The use of this optical diagno